Omeros | OMER - Despesas Operacionais





Despesas Operacionais Alterar Data
Adma Biologics USD 64.2M 12.21M 2026-03
Alnylam Pharmaceuticals USD 1.06B 160.97M 2026-06
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Cytokinetics USD 207.8M 7.22M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
Heron Therapeutics USD 40.55M 1.46M 2025-12
Immunic USD 23.33M 2.67M 2025-12
Insmed USD 526.79M 20.55M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
MacroGenics USD 42.87M 21.68M 2026-06
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 180.54M 7.79M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06